Expanding GOSTAR™ Small Molecules with 1 Million+ New SAR Data Points to Support Data-Driven Drug Design and Optimization Between March and November 2025, GOSTAR Small Molecules continued steady, high-quality growth across compounds, SAR,…Vinayak ManeDecember 9, 2025 Read More
Expanding GOSTARᵀᴹ TPD with 10K+ New Degraders for Smarter Drug Design and Strategic Decisions Between April and July 2025, the GOSTARᵀᴹ TPD database added 20% more content. More than…Vinayak ManeAugust 11, 2025 Read More
Excelra and AsedaSciences® announce a strategic Co-Marketing Agreement to provide scientists with single, easy-to-use platform, for small molecule toxicity assessment Schindellegi, Switzerland, June 2024 – Small molecule toxicity assessment remains a hurdle in drug development,…Prashant SharmaApril 7, 2025 Read More
GOSTAR™ SAR Database: Now Faster, Smarter, and More Efficient The GOSTAR™ SAR database has always been the gold standard for medicinal chemists and drug…Prashant SharmaApril 7, 2025 Read More
Orogen Therapeutics Partners with Excelra for GOSTAR® Partnership Strengthens Orogen Therapeutics’ AI-Driven Drug Discovery Platform HYDERABAD, India / WOBURN, Mass (Dec 13,…Prashant SharmaDecember 13, 2024 Read More
Excelra certified for third consecutive year – Great Place To Work Excelra is proud to announce that we have once again received the esteemed Great Place…Prashant SharmaMarch 6, 2024 Read More
Excelra acquires BISC Global, creating an international bioinformatics powerhouse with an industry-leading platform and service offering The acquisition extends Excelra's artificial intelligence, machine learning , and data science capabilities, and enhances…Prashant SharmaApril 19, 2023 Read More
BISC Global receives half a million euros to develop ML-based suite for accelerated antibody discovery and design January 31, 2023: BISC Global, a leading Bioinformatics, Biostatistics, and AI/ML consulting company with six…Prashant SharmaJanuary 31, 2023 Read More
Excelra partners with Patcore, Inc The partnership expands Excelra's scientific products footprint in the Japanese market Hyderabad, India / Tokyo,…Prashant SharmaSeptember 21, 2022 Read More
Excelra Partners with HotSpot Therapeutics to Enhance Allosteric Drug Discovery Efforts Hyderabad, India and Boston, U.S.A., (May 25, 2022): Excelra, a leading global data, and digital insights…Prashant SharmaMay 25, 2022 Read More